Select the image to view the label in detail.
KLOW research profile
What is being studied?
KLOW is a multi-component research blend rather than a single molecular entity. It combines a copper-binding tripeptide complex, the Lys-Pro-Val tripeptide, a thymosin-beta-derived research component and BPC-157 in one documented presentation.
The blend format is suited to controlled comparison of the combined preparation against its individual components. Published component studies cover copper-dependent matrix signalling, KPV transport and inflammatory-pathway assays, thymosin-beta/actin interactions and BPC-157 cell-migration models; they do not demonstrate that the mixture has a single established mechanism.
Research areas
- Blend-versus-component comparison in controlled cell-based assays
- Multi-pathway extracellular-matrix and cell-migration research
- Analytical assessment of component identity and blend consistency
Selected studies
-
Cell and animal study · 2008PepT1-mediated KPV uptake and signalling assays ↗
Investigated KPV transport and inflammatory signalling in cell assays and mouse models; it did not test KLOW.
-
Cell and tissue study · 2011BPC-157 and fibroblast migration through FAK-paxillin ↗
Investigated BPC-157 in rat tendon explants and cultured fibroblasts; it did not test a combined blend.
-
Related peptide study · 2003The actin-binding site on thymosin beta-4 ↗
Studied thymosin beta-4 and its actin-binding fragments in cell and tissue models. This does not verify the supplied TB-500 material or blend.
How to read this research
These papers study defined compounds in specific experimental systems or clinical trials. They do not test or certify this product, its batch or its prepared presentation. Component and related-peptide studies do not establish the effects of a finished blend. Findings are research context, not evidence of safety or suitability for personal use. For laboratory research only; no treatment, dosing or use advice is provided.
KLOW research record
Molecular identity and stated sequence or composition, alongside the batch, storage, dispatch and document record for this powder vial.
Molecular identity
Four-component peptide research blend
Sequence / composition
50mg GHK-Cu + 10mg KPV + 10mg TB-500 + 10mg BPC-157
Product record
The listing identifies the presentation, specification, storage record, dispatch status, and batch-document availability for the relevant product or batch.
Use restriction
For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.